mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.02 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.02 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |